November 16, 2026
Caribbean Producers (Jamaica) Limited (CPJ)
Unaudited financials for the nine months ended September 30, 2026:
Caribbean Producers (Jamaica) Limited (CPJ) for the nine months ended September 30, 2026 reported a 33% decrease in Revenue totalling US$97.64 million compared to US$146.50 million in the corresponding period last year. Revenue for the third quarter declined by 43% to US$33.17 million compared to US$58.14 million for the comparable quarter of 2025, although it was 6% above the preceding quarter. Management noted that the decline was primarily attributable to continued weakness in Jamaica’s hospitality sector. Hotel room availability and occupancy remained well below pre-Hurricane Melissa levels, with several properties closed for refurbishment and expected to reopen between November 2026 and May 2027. Jamaica revenue declined by 30% to US$73.84 million, while St. Lucia contributed US$24.76 million, supported by retail, trade and depot sales.
Direct Expenses amounted to US$73.14 million (2025: US$105.53 million), representing a decrease of 31% year over year. Consequently, Gross Profit decreased by 40% to US$24.50 million compared to US$40.97 million for the nine months ended September 30, 2025. Gross Profit for the third quarter amounted to US$7.96 million, compared to US$16.80 million reported for the corresponding quarter of 2025. The gross margin declined to 25.1% from 28.0% for the nine months, and to 24.0% from 28.9% for the quarter. Management noted that this primarily reflects lower sales volumes and the resulting under-absorption of fixed warehousing and distribution costs.
Finance and Other Operating Income increased to US$1.20 million from US$92,039 in 2025, mainly reflecting an insurance recovery of US$0.99 million recognised in the third quarter. Administration and Other Operating Expenses decreased by 20% to US$27.42 million from US$34.34 million in the prior year. Management noted that first-half expenses included approximately US$3.0 million of non-recurring costs related to the Group’s restructuring, hurricane repairs, port demurrage and the disposal of hurricane-damaged goods. Third-quarter operating expenses were approximately 44% below the corresponding quarter of 2025. The Group also recorded a Net Impairment Gain on Trade Receivables of US$1.03 million, compared to a net impairment loss of US$186,198 in 2025.
Despite the insurance recovery and the impairment gain, the Group recorded an Operating Loss of US$693,754 for the nine months ended September 30, 2026, compared to Operating Profit of US$6.54 million in 2025. For the third quarter, the Group recorded an Operating Loss of US$198,939, compared to Operating Profit of US$316,348 in the corresponding quarter of 2025.
Finance Costs decreased by 29% to US$2.33 million from US$3.29 million in the prior year, reflecting the Group’s focus on managing debt and reducing financing costs. As a result, Loss Before Taxation amounted to US$3.02 million, compared to Profit Before Taxation of US$3.25 million in 2025. For the third quarter, Loss Before Taxation narrowed to US$925,968 from US$1.19 million in the corresponding quarter of 2025.
The Group recorded a Taxation Credit of US$601,347 for the nine months ended September 30, 2026, compared to a Taxation Charge of US$1.00 million in 2025. Consequently, Net Loss for the nine months amounted to US$2.42 million, compared to Net Profit of US$2.25 million in the prior year. For the third quarter, the Net Loss narrowed to US$780,763 from US$1.04 million in the corresponding quarter of 2025.
Net Loss Attributable to Stockholders of the Company amounted to US$2.12 million, compared to Net Profit Attributable to Stockholders of US$2.52 million in 2025. For the third quarter, Net Loss Attributable to Stockholders amounted to US$614,342, compared to US$739,263 in the prior year’s quarter.
Consequently, Loss Per Stock Unit for the nine months amounted to US$0.0019, or approximately J$0.31, compared to Earnings Per Stock Unit of US$0.0023, or approximately J$0.37. These conversions use exchange rates of J$159.8076 for 2026 and J$161.0583 for 2025. Loss Per Stock Unit for the third quarter amounted to US$0.0006, or approximately J$0.09, compared to US$0.0007, or approximately J$0.11, for the corresponding quarter of 2025. The twelve-month trailing EPS was approximately US$0.0053, or approximately J$0.85, and the number of shares used in these calculations was 1,100,000,000.
Notably, CPJ’s stock price closed the trading period on November 13, 2026 at J$7.25, with a corresponding P/E ratio of approximately 8.57x.
Balance Sheet Highlights
The Group’s Total Assets amounted to US$108.58 million at September 30, 2026, representing a 5% decrease from US$114.88 million in 2025. The decrease was mainly driven by Inventories, which fell to US$36.84 million from US$42.60 million, and Trade and Other Receivables, which declined to US$29.58 million from US$32.70 million. Property, Plant and Equipment also decreased to US$14.57 million from US$17.02 million, and Right-of-Use Assets to US$10.60 million from US$12.65 million. These declines were partly offset by higher Cash and Cash Equivalents of US$4.56 million (2025: US$2.77 million) and an increase in Due from Parent Company to US$5.99 million from US$3.41 million. Management noted that operating cash flow improved to an inflow of US$8.13 million from an outflow of US$4.41 million in 2025, reflecting tighter working capital management.
Shareholders’ Equity increased to US$46.53 million from US$40.75 million in 2025, representing a book value per share of approximately US$0.042, or J$6.76, compared to US$0.037, or J$5.97.

Disclaimer:
Analyst Certification -The views expressed in this research report accurately reflect the personal views of Mayberry Investments Limited Research Department about those issuer (s) or securities as at the date of this report. Each research analyst (s) also certify that no part of their compensation was, is, or will be, directly or indirectly, related to the specific recommendation(s) or view (s) expressed by that research analyst in this research report.
Company Disclosure -The information contained herein has been obtained from sources believed to be reliable, however its accuracy and completeness cannot be guaranteed. You are hereby notified that any disclosure, copying, distribution or taking any action in reliance on the contents of this information is strictly prohibited and may be unlawful. Mayberry may effect transactions or have positions in securities mentioned herein. In addition, employees of Mayberry may have positions and effect transactions in the securities mentioned herein.